S . P . Butt et al .: J Extra Corpor Technol 2024 , 56 , 136 – 144 143
in patients undergoing cardiac surgery requiring cardiopulmonary bypass . Perfusion . 2011 ; 26 ( 6 ): 487 – 495 .
21 . Warnock LB , Huang D . Heparin . Jul 10 . In : StatPearls [ Internet ]. Treasure Island , FL : StatPearls Publishing ; 2024 . PMID : 30855835 .
22 . Edwards JK , Sniecinski RM , Scott KJ . Non-antithrombinmediated heparin resistance during cardiac surgery : two case reports . AA Pract . 2019 ; 13 ( 6 ): 211 – 214 .
23 . Knapik P , Cieśla D , Przybylski R , Knapik T . The influence of heparin resistance on postoperative complications in patients undergoing coronary surgery . Med Sci Monit . 2012 ; 18 ( 2 ): CR105 – CR111 .
24 . Sniecinski RM , Bennett-Guerrero E , Shore-Lesserson L . Anticoagulation management and heparin resistance during cardiopulmonary bypass : A survey of Society of Cardiovascular Anesthesiologists members . Anesth Analg . 2019 ; 129 ( 2 ): e41 – e44 .
25 . Avidan MS , Levy JH , van Aken H , Feneck RO , Latimer RD , Ott E , et al . Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass . J Thorac Cardiovasc Surg . 2005 ; 130:107 – 113 .
26 . Stammers AH , Francis SG , Miller RM , Nostro A , Tesdahl EA , Mongero LB . Application of goal-directed therapy for the use of concentrated antithrombin for heparin resistance during cardiac surgery . Perfusion . 2020 ; 36 ( 2 ): 171 – 182 .
27 . Puis L , Milojevic M , Boer C , De Somer FMJJ , Gudbjartsson T , van den Goor J , et al . EACTS / EACTA / EBCP Committee Reviewers . 2019 EACTS / EACTA / EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery . Interact Cardiovasc Thorac Surg . 2020 ; 30 ( 2 ): 161 – 202 .
28 . Tibi P , McClure RS , Huang J , Baker RA , Fitzgerald D , Mazer CD , et al . STS / SCA / AMSECT / SABM update to the clinical practice guidelines on patient blood management . Ann Thorac Surg . 2021 ; 112 ( 3 ): 981 – 1004 .
29 . Patnaik MM , Moll S . Inherited antithrombin deficiency : a review . Haemophilia . 2008 ; 14 ( 6 ): 1229 – 1239 .
30 . Bull BS , Korpman RA , Huse WM , Briggs BD . Heparin therapy during extracorporeal circulation . I . Problems inherent in existing heparin protocols . J Thorac Cardiovasc Surg . 1975 ; 69 ( 5 ): 674 – 684 .
31 . Young JA , Kisker CT , Doty DB . Adequate anticoagulation during cardiopulmonary bypass determined by activated clotting time and the appearance of fibrin monomer . Ann Thorac Surg . 1978 ; 26 ( 3 ): 231 – 240 .
32 . Metz S , Keats AS . Low activated coagulation time during cardiopulmonary bypass does not increase postoperative bleeding . Ann Thorac Surg . 1990 ; 49 ( 3 ): 440 – 444 .
33 . Jung HJ , Kim JB , Im KS , Oh SH , Lee JM . Heparin resistance during cardiopulmonary bypass . J Cardiovasc Med . 2009 ; 10 ( 12 ): 940 – 941 .
34 . Kearon C , Akl EA , Ornelas J , Blaivas AJ , Jiménez D , Bounameaux H , et al . Antithrombotic therapy for VTE disease . Chest . 2016 ; 149 ( 2 ): 315 – 352 .
35 . Levy JH , Sniecinski RM , Rocca B , Ghadimi K , Douketis JD , Frère C , et al . Defining heparin resistance : communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis . J Thromb Haemost . 2023 ; 21 ( 12 ): 3649 – 3657 .
36 . García D , Baglin T , Weitz JI , Samama M . Parenteral anticoagulants . Chest . 2012 ; 141 ( 2 ): e24S – e43S .
37 . Kanbak M . The treatment of heparin resistance with antithrombin III in cardiac surgery . Can J Anaesth . 1999 ; 46 ( 6 ): 581 – 585 .
38 . Mahmood S , Bilal H , Zaman M , Tang A . Is a fully heparinbonded cardiopulmonary bypass circuit superior to a standard cardiopulmonary bypass circuit ? Interact Cardiovasc Thorac Surg . 2012 ; 14 ( 4 ): 406 – 414 .
39 . Kitchen S . Problems in laboratory monitoring of heparin dosage . Br J Haematol . 2000 ; 111 ( 2 ): 397 – 406 .
40 . McMichael ABV , Ryerson L , Ratano D , Fan E , Faraoni D , Annich GM . 2021 ELSO adult and pediatric anticoagulation guidelines . ASAIO J . 2022 ; 68 ( 3 ): 303 – 310 .
41 . Dietrich W , Spannagl M , Schramm W , Vogt W , Barankay A , Richter J . The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass . The J Thorac Cardiovasc Surg . 1991 ; 102 ( 4 ): 505 – 514 .
42 . Ranucci M , Frigiola A , Menicanti L , Cazzaniga A , Soro G , Isgrò G . Risk factors for fatal myocardial infarction after coronary bypass graft surgery . Eur J Anaesthesiol . 2001 ; 18 ( 5 ): 322 – 329 .
43 . Saydam O , Atay M , Sßerefli D , Doğancı S , Kumabasar U , Yılmaz M , et al . Preoperative low-molecular-weight heparin prophylaxis associated with increased heparin resistance frequency in on-pump coronary artery bypass graft surgery . Cardiol Res Pract . 2019 ; 2019:1 – 5 .
44 . Kimura Y , Okahara S , Abo K , Koyama Y , Kuriyama M , Ono K , et al . Infective endocarditis is a risk factor for heparin resistance in adult cardiovascular surgical procedures : a retrospective study . J Cardiothorac Vasc Anesth . 2021 ; 35 ( 12 ): 3568 – 3573 .
45 . Sniecinski R , Szlam F , Chen EP , Bader SO , Levy JH , Tanaka KA . Antithrombin deficiency increases thrombin activity after prolonged cardiopulmonary bypass . Anesth Analg . 2008 ; 106 ( 3 ): 713 – 718 .
46 . Boysan E , Cırcı R , Beyazal OF , Sßener E . Bivalirudin for cardiopulmonary bypass in a patient with heparin allergy . J Cardiothorac Surg . 2023 ; 18 ( 1 ): 258 .
47 . Nikolaidis N , Velissaris T , Ohri SK . Bivalirudin anticoagulation for cardiopulmonary bypass : an unusual case . Tex Heart Inst J . 2007 ; 34 ( 1 ): 115 – 118 .
48 . Gosselin R , Douxfils J . Ecarin based coagulation testing . Am J Hematol . 2020 ; 95 ( 7 ): 863 – 869 .
49 . Van Cott EM , Roberts AJ , Dager WE . Laboratory monitoring of parenteral direct thrombin inhibitors . Semin Thromb Hemost . 2017 ; 43 ( 03 ): 270 – 276 .
50 . Häfner G , Roser M , Nauck M . Methods for the monitoring of direct thrombin inhibitors . Semin Thromb Hemost . 2002 ; 28 ( 5 ): 425 – 430 .
51 . Boinot C , Lanquetot H , Macchi L , Charriëre JM , Menu P . Circulation extracorporelle sous lépirudine ( Refludan â ) dans un contexte de thrombopénie induite par l ’ héparine . Ann Fr Anesth Reanim . 2003 ; 22 ( 7 ): 635 – 638 .
52 . Greinacher A , Völpel H , Janssens U , Hach-Wunderle V , Kemkes-Matthes B , Eichler P , et al . Recombinant hirudin ( Lepirudin ) provides safe and effective anticoagulation in patients with Heparin-Induced thrombocytopenia . Circulation . 1999 ; 99 ( 1 ): 73 – 80 .
53 . Zucker MB , Koster A , Prats J , LaDuca FM . Sensitivity of a modified ACT test to levels of bivalirudin used during cardiac surgery . J Extra Corp Technol . 2005 ; 37 ( 4 ): 364 – 368 .
54 . Jabr K , Johnson JH , McDonald MH , Walsh DL , Martin WD , Johnson AC , Pickett JM , Shantha-Martin U . Plasma-modified ACT can be used to monitor bivalirudin ( Angiomax ) anticoagulation for on-pump cardiopulmonary bypass surgery in a patient with heparin-induced thrombocytopenia . J Extra Corpor Technology . 2004 ; 36 ( 2 ): 174 – 177 .